102 results found.
          
DePuy Synthes Reports 2Q19 Revenue of $2,230.9MM, -1.3% vs. 2Q18
DePuy Synthes reports 2Q19 orthopedic revenue of USD $2,230.9MM, -1.3% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Global Orthopedic Market Revenue to Exceed $61 Billion in 2023
The global orthopedic market will exceed US $61 billion in revenue in 2023.
Future-Minded Orthopedic and Spine Surgeons Will Advise Industry Stakeholders and Manufacturing Community at OMTEC® 2019
Future-minded orthopedic and spine surgeons will advise industry stakeholders and the manufacturing community at OMTEC® 2019
Orthopedic Industry Revenue Reaches $51 Billion in 2018
By Mike Evers Download Your Copies
DePuy Synthes Reports 1Q19 Revenue of $2,203MM, -2.1% vs. 1Q18
DePuy Synthes reports 1Q19 orthopedic revenue of USD $2,203MM, -2.1% vs. 1Q18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Anika Therapeutics Reports 4Q18 Orthobiologic Revenue of $23.8MM, -5.3% vs. 4Q17
Anika Therapeutics posts 4Q18 orthobiologic revenue of USD $23.8MM, -5.3% vs. 4Q17, with
DePuy Synthes Reports 4Q18 Revenue of $2,205.1MM, -0.5% vs. 4Q17
DePuy Synthes reports 4Q18 orthopaedic revenue of $2,205.1MM, -0.5% vs. 4Q17, with full year...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
DePuy Synthes Reports 3Q18 Revenue, -4.2% vs. 3Q17
DePuy Synthes’ 3Q18 orthopaedic performance remains challenged with revenue of US $2,111.3MM, -4.2% vs. 3Q17.
NuVasive Announces New CEO
NuVasive named J. Christopher Barry to succeed Gregory T. Lucier as Chief Executive Officer, effective next month. Mr. Lucier wil...
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
Spine Company Sales: ORTHOWORLD Top Ten
Spine...
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Globus Medical Reports 2Q18 Revenue
Globus Medical reported 2Q18 revenue of US $173.4MM, +13.8% vs. 2Q17, and 1H18 revenue of $347.8MM, +12.8% v...
DePuy Synthes Reports 2Q18 Orthopaedic Revenue -1.4% YoY
DePuy Synthes reported 2Q18 orthopaedic revenue of US $2,261.0MM, -1.4% vs. 2Q17, and 1H18 revenue of 
Stryker's David Floyd Retiring; Leadership Changes Occur
David Floyd, Group President of Orthopaedics at Stryker, will retire on June 30, 2019.
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
DePuy Synthes Reports 1Q18 Orthopaedic Revenue
DePuy Synthes reported 1Q18 orthopaedic revenue of US $2,250.0MM, -1.1% vs. 1Q17.
Smith & Nephew Appoints Namal Nawana as CEO
Smith & Nephew has appointed Mr. Namal Nawana as Chief Executive Officer and successor to Mr. Olivier Bohuon, effective May 2018.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
OrthoPediatrics Posts 4Q17 and 2017 Revenue Growth Over 20%
OrthoPediatrics posted 4Q17 revenue of US $11.7MM, +23.7% vs. 4Q16, and 2017 revenue of $45.6...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group